Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.

Leukemia - 1 Nov 2023

Eckardt Jan-Niklas, Bill Marius, Rausch Christian, Metzeler Klaus, Spiekermann Karsten, Stasik Sebastian, Sauer Tim, Scholl Sebastian, Hochhaus Andreas, Crysandt Martina, Brümmendorf Tim H, Krug Utz, Wörmann Bernhard, Hiddemann Wolfgang, Görlich Dennis, Sauerland Cristina, Steffen Björn, Einsele Hermann, Neubauer Andreas, Burchert Andreas, Schäfer-Eckart Kerstin, Berdel Wolfgang E, Schliemann Christoph, Krause Stefan W, Hänel Mathias, Hanoun Maher, Kaufmann Martin, Fransecky Lars, Braess Jan, Ruhnke Leo, Schetelig Johannes, Middeke Jan Moritz, Serve Hubert, Baldus Claudia D, Platzbecker Uwe, Müller-Tidow Carsten, Bornhäuser Martin, Herold Tobias, Thiede Christian, Röllig Christoph

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chronic Myeloid Leukemia Treatments

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Share to Nuclear Proteins

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 37679502
DOI: 10.1038/s41375-023-02016-6
PMCID: PMC10624615

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.PMID 37679502Read ↗

NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?Semantic proximity Read ↗

The NPM1 mutation type has no impact on survival in cytogenetically normal AML.Semantic proximity Read ↗

Secondary‐type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1Semantic proximity Read ↗

Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.Semantic proximity Read ↗

Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.Semantic proximity Read ↗

Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.Semantic proximity Read ↗

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?Semantic proximity Read ↗

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaSemantic proximity Read ↗

Biological and clinical consequences of NPM1 mutations in AML.Semantic proximity Read ↗

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.Semantic proximity Read ↗

Acute Myeloid Leukaemia with Normal Cytogenetics and NPM1-Mutation: Impact of Mutation Topography on OutcomesSemantic proximity Read ↗

A scale of "bad" co-mutations in NPM1-driven AML.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.